FUSIONPHARM offers guaranteed financing to licensed cannabis industry operators
PR Newswire
DENVER, May 14, 2013
DENVER , May 14, 2013 /PRNewswire/ -- FusionPharm, Inc. (OTC: FSPM), the developer of the patent pending PharmPods™ hydroponic cultivation system ( www.pharmpods.com ), today announced that it will immediately begin offering guaranteed financing to state licensed cannabis cultivators via its licensee, Colorado based Meadpoint Venture Partners. PharmPod containers utilize state of the art lighting systems, super-efficient HVAC systems and automated control systems to achieve outstanding results in controlled environment agriculture.
"Given the problems with banking and traditional capital sources in the cannabis industry, we realize that providing financing to licensed cultivators will allow us to maximize our sales potential," said FusionPharm CEO Scott Dittman . "We expect sales of our container systems in the cannabis space to increase substantially with the availability of financing and the growth of the cannabis industry in our home state of Colorado and the many other States that will soon issue cultivation permits."
About FusionPharm, Inc.
FusionPharm, Inc. was organized to capitalize on opportunities present in the rapidly growing organic/local food and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods(TM) advanced hydroponic cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Using advanced lighting technology, cutting edge growing media and proprietary cultivation techniques, a single PharmPod is capable of growing more produce than one full acre of traditional agriculture in less than half the time using 90% less water than traditional agriculture, with no harmful pesticides or herbicides.
NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.
Contact: FusionPharm, Inc.
info@fusionpharminc.com
SOURCE FusionPharm, Inc.
